| SECTION I: HEALTH APPRAISAL AND RISK ASSESSMENT |
|
|
1 Benefits and Risks Associated with Physical Activity |
|
|
2 | |
|
Physical Activity and Fitness Terminology |
|
|
2 | |
|
Public Health Perspective for Current Recommendations |
|
|
5 | |
|
Benefits of Regular Physical Activity and/or Exercise |
|
|
8 | |
|
Risks Associated with Exercise |
|
|
8 | |
|
Sudden Cardiac Death among Young Individuals |
|
|
10 | |
|
Exercise-Related Cardiac Events in Adults |
|
|
11 | |
|
Exercise Testing and the Risk of Cardiac Events |
|
|
12 | |
|
Risks of Cardiac Events during Cardiac Rehabilitation |
|
|
12 | |
|
Prevention of Exercise-Related Cardiac Events |
|
|
12 | |
|
|
|
15 | |
|
2 Preparticipation Health Screening and Risk Stratification |
|
|
18 | |
|
Preparticipation Screening |
|
|
19 | |
|
Self-Guided Screening for Physical Activity |
|
|
19 | |
|
Professionally Guided Screening for Physical Activity |
|
|
22 | |
|
|
|
22 | |
|
Undisclosed or Unavailable Cardiovascular Disease Risk-Factor Information |
|
|
24 | |
|
Known Cardiovascular, Pulmonary, and Metabolic Disease |
|
|
25 | |
|
Major Signs/Symptoms Suggestive of Cardiovascular, Pulmonary, and Metabolic Disease |
|
|
25 | |
|
Atherosclerotic Cardiovascular Disease Risk Factors |
|
|
25 | |
|
Exercise Testing and Participation Recommendations Based on Risk Category |
|
|
31 | |
|
Exercise Testing and Testing Supervision Recommendations Based on Risk Category |
|
|
31 | |
|
Risk Stratification for Cardiac Patients |
|
|
37 | |
|
|
|
39 | |
| SECTION II: EXERCZSE TESTING |
|
|
3 Pre-Exercise Evaluations |
|
|
42 | |
|
Medical History, Physical Examination, and Laboratory Tests |
|
|
42 | |
|
|
|
46 | |
|
|
|
48 | |
|
|
|
50 | |
|
|
|
51 | |
|
Contraindications to Exercise Testing |
|
|
53 | |
|
|
|
53 | |
|
|
|
58 | |
|
|
|
58 | |
|
4 Health-Rlated Physical Fitness Testing and Interpretation |
|
|
60 | |
|
Purposes of Health-Related Fitness Testing |
|
|
60 | |
|
Basic Principles and Guidelines |
|
|
60 | |
|
|
|
61 | |
|
|
|
61 | |
|
|
|
62 | |
|
|
|
62 | |
|
|
|
63 | |
|
|
|
69 | |
|
|
|
70 | |
|
|
|
70 | |
|
Cardiorespiratory Fitness |
|
|
71 | |
|
The Concept of Maximal Oxygen Uptake |
|
|
72 | |
|
Maximal versus Submaximal Exercise Testing |
|
|
73 | |
|
|
|
74 | |
|
Cardiorespiratory Test Sequence and Measures |
|
|
80 | |
|
Test Termination Criteria |
|
|
82 | |
|
Interpretation of Results |
|
|
84 | |
|
Muscular Strength and Muscular Endurance |
|
|
85 | |
|
|
|
87 | |
|
|
|
88 | |
|
|
|
90 | |
|
|
|
93 | |
|
|
|
96 | |
|
|
|
98 | |
|
A Comprehensive Health Fitness Evaluation |
|
|
101 | |
|
|
|
102 | |
|
5 Clinical Exercise Testing |
|
|
105 | |
|
Indications and Applications |
|
|
105 | |
|
Diagnostic Exercise Testing |
|
|
105 | |
|
Exercise Testing for Disease Severity and Prognosis |
|
|
106 | |
|
Exercise Testing after Myocardial Infarction |
|
|
107 | |
|
Functional Exercise Testing |
|
|
107 | |
|
|
|
111 | |
|
|
|
112 | |
|
Upper-Body Exercise Testing |
|
|
113 | |
|
Testing for Return to Work |
|
|
113 | |
|
Measurements during Exercise Testing |
|
|
116 | |
|
Heart Rate and Blood Pressure |
|
|
116 | |
|
Electrocardiographic Monitoring |
|
|
118 | |
|
Subjective Ratings and Symptoms |
|
|
120 | |
|
Gas Exchange and Ventilatory Responses |
|
|
121 | |
|
|
|
121 | |
|
Indications for Exercise Test Termination |
|
|
122 | |
|
|
|
122 | |
|
|
|
123 | |
|
Exercise Echocardiography |
|
|
123 | |
|
|
|
123 | |
|
Pharmacologic Stress Testing |
|
|
129 | |
|
Computed Tomography in the Assessment of Coronary Artery Disease |
|
|
130 | |
|
Supervision of Exercise Testing |
|
|
131 | |
|
|
|
132 | |
|
6 Interpretation of Clinical Exercise Test Data |
|
|
135 | |
|
Exercise Testing as a Screening Tool for Coronary Artery Disease |
|
|
135 | |
|
Interpretation of Responses to Graded Exercise Testing |
|
|
136 | |
|
|
|
139 | |
|
|
|
139 | |
|
Electrocardiograph Waveforms |
|
|
140 | |
|
Limiting Signs and Symptoms |
|
|
143 | |
|
Gas Exchange and Ventilatory Responses |
|
|
144 | |
|
Diagnostic Value of Exercise Testing |
|
|
145 | |
|
|
|
145 | |
|
|
|
146 | |
|
|
|
147 | |
|
Comparison with Imaging Stress Tests |
|
|
147 | |
|
Prognostic Applications of the Exercise Test |
|
|
147 | |
|
|
|
148 | |
| SECTION III: |
|
152 | |
|
7 General Principles of Exercise Prescription |
|
|
152 | |
|
|
|
152 | |
|
Components of the Exercise Training Session |
|
|
153 | |
|
Aerobic (Cardiovascular Endurance) Exercise |
|
|
154 | |
|
Quantity of Exercise: How Much Exercise Is Enough for Health/Fitness Benefits? |
|
|
154 | |
|
Aerobic (Cardiovascular) Exercise Mode (Type) |
|
|
163 | |
|
The Components of the Aerobic (Cardiovascular Endurance) Exercise Prescription: The FITT Principle or Frequency, Intensity, Time, and Type of Exercise |
|
|
165 | |
|
|
|
165 | |
|
|
|
165 | |
|
Frequency of Resistance Exercise |
|
|
168 | |
|
Types of Resistance Exercises |
|
|
168 | |
|
Volume of Resistance Exercise (Repetitions and Sets) |
|
|
169 | |
|
Resistance Exercise Technique |
|
|
170 | |
|
|
|
170 | |
|
Flexibility Exercise (Stretching) |
|
|
171 | |
|
|
|
174 | |
|
Exercise Program Supervision |
|
|
174 | |
|
Strategies for Improving Exercise Adoption and Maintenance |
|
|
175 | |
|
|
|
180 | |
|
8 Exercise Prescription for Healthy Populations and Special Considerations |
|
|
183 | |
|
|
|
183 | |
|
|
|
183 | |
|
|
|
184 | |
|
|
|
185 | |
|
|
|
187 | |
|
|
|
188 | |
|
|
|
189 | |
|
|
|
189 | |
|
|
|
190 | |
|
|
|
191 | |
|
|
|
192 | |
|
|
|
194 | |
|
Environmental Considerations |
|
|
194 | |
|
Exercise in Hot Environments |
|
|
194 | |
|
Exercise in Cold Environments |
|
|
198 | |
|
Exercise in High-Altitude Environments |
|
|
201 | |
|
|
|
204 | |
|
9 Exercise Prescription for Patients with Cardiac Disease |
|
|
207 | |
|
Inpatient Rehabilitation Programs |
|
|
207 | |
|
|
|
210 | |
|
|
|
210 | |
|
|
|
210 | |
|
|
|
210 | |
|
Outpatient Exercise Programs |
|
|
211 | |
|
|
|
212 | |
|
Types of Outpatient Exercise Programs |
|
|
216 | |
|
|
|
216 | |
|
Exercise Prescription without a Preliminary Exercise Test |
|
|
218 | |
|
Resistance Training for Cardiac Patients |
|
|
219 | |
|
Exercise Training for Return to Work |
|
|
222 | |
|
|
|
222 | |
|
10 Exercise Prescription for Clinical Populations |
|
|
225 | |
|
|
|
225 | |
|
|
|
225 | |
|
|
|
226 | |
|
|
|
228 | |
|
|
|
228 | |
|
|
|
231 | |
|
|
|
232 | |
|
|
|
233 | |
|
|
|
234 | |
|
|
|
237 | |
|
|
|
237 | |
|
|
|
241 | |
|
|
|
244 | |
|
|
|
245 | |
|
|
|
245 | |
|
Human Immunodeficiency Virus |
|
|
246 | |
|
|
|
246 | |
|
|
|
247 | |
|
|
|
248 | |
|
|
|
248 | |
|
|
|
249 | |
|
|
|
250 | |
|
|
|
252 | |
|
Exercise Prescription/Special Considerations |
|
|
252 | |
|
|
|
253 | |
|
|
|
253 | |
|
|
|
254 | |
|
Behavioral Weight Loss Program Recommendations |
|
|
255 | |
|
|
|
256 | |
|
|
|
256 | |
|
|
|
256 | |
|
Peripheral Artery Disease |
|
|
258 | |
|
|
|
259 | |
|
|
|
259 | |
|
|
|
260 | |
|
|
|
261 | |
|
|
|
262 | |
|
|
|
264 | |
|
|
|
264 | |
|
|
|
265 | |
|
|
|
266 | |
| SECTION IV: APPENDICES |
|
|
Appendix A Common Medications |
|
|
274 | |
|
Appendix B Medical Emergency Management |
|
|
292 | |
|
Appendix C Electrocardiogram Interpretation |
|
|
302 | |
|
Appendix D American College of Sports Medicine Certifications |
|
|
310 | |
| Index |
|
363 | |
